Skip to main content
Erschienen in: Journal of Neurology 3/2018

01.02.2018 | Original Communication

Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson’s disease

verfasst von: Kazuya Kawabata, Hirohisa Watanabe, Kazuhiro Hara, Epifanio Bagarinao, Noritaka Yoneyama, Aya Ogura, Kazunori Imai, Michihito Masuda, Takamasa Yokoi, Reiko Ohdake, Yasuhiro Tanaka, Takashi Tsuboi, Tomohiko Nakamura, Masaaki Hirayama, Mizuki Ito, Naoki Atsuta, Satoshi Maesawa, Shinji Naganawa, Masahisa Katsuno, Gen Sobue

Erschienen in: Journal of Neurology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Cognitive deficits in Parkinson’s disease (PD) are heterogeneous entities, but a relationship between the heterogeneity of cognitive deficits and resting-state network (RSN) changes remains elusive. In this study, we examined five sub-domain scores according to Addenbrooke’s Cognitive Examination-Revised (ACE-R) for the cognitive evaluation and classification of 72 non-demented patients with PD. Twenty-eight patients were classified as PD with normal cognition (PD-NC). The remaining 44 were subdivided into the following 2 groups using a hierarchical cluster analysis: 20 with a predominant decrease in memory (PD with amnestic cognitive deficits: PD-A) and 24 with good memory who exhibited a decrease in other sub-domains (PD with non-amnestic cognitive deficits: PD-NA). We used an independent component analysis of RS-fMRI data to investigate the inter-group differences of RSN. Compared to the controls, the PD-A showed lower FC within the ventral default mode network (vDMN) and the visuospatial network. On the other hand, the PD-NA showed lower FC within the visual networks and the cerebellum–brainstem network. Significant differences in the FC within the vDMN and cerebellum–brainstem network were observed between the PD-A and PD-NA, which provided a good discrimination between PD-A and PD-NA using a support vector machine. Distinct patterns of cognitive deficits correspond to different RSN changes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005) Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol 58:773–776CrossRefPubMed Aarsland D, Perry R, Brown A, Larsen JP, Ballard C (2005) Neuropathology of dementia in Parkinson’s disease: a prospective, community-based study. Ann Neurol 58:773–776CrossRefPubMed
2.
Zurück zum Zitat Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y, Iwai K, Ito K, Yanagisawa N, Sobue G (2003) Occipital hypoperfusion in Parkinson’s disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74:419–422CrossRefPubMedPubMedCentral Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y, Iwai K, Ito K, Yanagisawa N, Sobue G (2003) Occipital hypoperfusion in Parkinson’s disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74:419–422CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Agosta F, Canu E, Stefanova E, Sarro L, Tomic A, Spica V, Comi G, Kostic VS, Filippi M (2014) Mild cognitive impairment in Parkinson’s disease is associated with a distributed pattern of brain white matter damage. Hum Brain Mapp 35:1921–1929CrossRefPubMed Agosta F, Canu E, Stefanova E, Sarro L, Tomic A, Spica V, Comi G, Kostic VS, Filippi M (2014) Mild cognitive impairment in Parkinson’s disease is associated with a distributed pattern of brain white matter damage. Hum Brain Mapp 35:1921–1929CrossRefPubMed
4.
Zurück zum Zitat Agosta F, Kostic VS, Davidovic K, Kresojevic N, Sarro L, Svetel M, Stankovic I, Comi G, Klein C, Filippi M (2013) White matter abnormalities in Parkinson’s disease patients with glucocerebrosidase gene mutations. Mov Disord 28:772–778CrossRefPubMed Agosta F, Kostic VS, Davidovic K, Kresojevic N, Sarro L, Svetel M, Stankovic I, Comi G, Klein C, Filippi M (2013) White matter abnormalities in Parkinson’s disease patients with glucocerebrosidase gene mutations. Mov Disord 28:772–778CrossRefPubMed
5.
6.
Zurück zum Zitat Baciu M, Boudiaf N, Cousin E, Perrone-Bertolotti M, Pichat C, Fournet N, Chainay H, Lamalle L, Krainik A (2016) Functional MRI evidence for the decline of word retrieval and generation during normal aging. Age (Dordr) 38:3CrossRef Baciu M, Boudiaf N, Cousin E, Perrone-Bertolotti M, Pichat C, Fournet N, Chainay H, Lamalle L, Krainik A (2016) Functional MRI evidence for the decline of word retrieval and generation during normal aging. Age (Dordr) 38:3CrossRef
7.
Zurück zum Zitat Baggio HC, Sala-Llonch R, Segura B, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C (2014) Functional brain networks and cognitive deficits in Parkinson’s disease. Hum Brain Mapp 35:4620–4634CrossRefPubMed Baggio HC, Sala-Llonch R, Segura B, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C (2014) Functional brain networks and cognitive deficits in Parkinson’s disease. Hum Brain Mapp 35:4620–4634CrossRefPubMed
8.
Zurück zum Zitat Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C (2015) Cognitive impairment and resting-state network connectivity in Parkinson’s disease. Hum Brain Mapp 36:199–212CrossRefPubMed Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C (2015) Cognitive impairment and resting-state network connectivity in Parkinson’s disease. Hum Brain Mapp 36:199–212CrossRefPubMed
9.
Zurück zum Zitat Barkhof F, Haller S, Rombouts SA (2014) Resting-state functional MR imaging: a new window to the brain. Radiology 272:29–49CrossRefPubMed Barkhof F, Haller S, Rombouts SA (2014) Resting-state functional MR imaging: a new window to the brain. Radiology 272:29–49CrossRefPubMed
10.
Zurück zum Zitat Beckmann CF, DeLuca M, Devlin JT, Smith SM (2005) Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci 360:1001–1013CrossRefPubMedPubMedCentral Beckmann CF, DeLuca M, Devlin JT, Smith SM (2005) Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci 360:1001–1013CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Berankova D, Janousova E, Mrackova M, Eliasova I, Kostalova M, Skutilova S, Rektorova I (2015) Addenbrooke’s cognitive examination and individual domain cut-off scores for discriminating between different cognitive subtypes of parkinson’s disease. Parkinsons Dis 2015:579417PubMedPubMedCentral Berankova D, Janousova E, Mrackova M, Eliasova I, Kostalova M, Skutilova S, Rektorova I (2015) Addenbrooke’s cognitive examination and individual domain cut-off scores for discriminating between different cognitive subtypes of parkinson’s disease. Parkinsons Dis 2015:579417PubMedPubMedCentral
12.
Zurück zum Zitat Birn RM, Kenworthy L, Case L, Caravella R, Jones TB, Bandettini PA, Martin A (2010) Neural systems supporting lexical search guided by letter and semantic category cues: a self-paced overt response fMRI study of verbal fluency. Neuroimage 49:1099–1107CrossRefPubMed Birn RM, Kenworthy L, Case L, Caravella R, Jones TB, Bandettini PA, Martin A (2010) Neural systems supporting lexical search guided by letter and semantic category cues: a self-paced overt response fMRI study of verbal fluency. Neuroimage 49:1099–1107CrossRefPubMed
13.
Zurück zum Zitat Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE (2011) Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med 52:848–855CrossRefPubMed Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE (2011) Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J Nucl Med 52:848–855CrossRefPubMed
14.
Zurück zum Zitat Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE (1999) Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia. Neurology 52:541–546CrossRefPubMed Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE (1999) Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia. Neurology 52:541–546CrossRefPubMed
15.
Zurück zum Zitat Caillava-Santos F, Margis R, de Mello Rieder CR (2015) Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods. Neuropsychiatr Dis Treat 11:1175–1180CrossRefPubMedPubMedCentral Caillava-Santos F, Margis R, de Mello Rieder CR (2015) Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods. Neuropsychiatr Dis Treat 11:1175–1180CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Chang C-C (2011) LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol 2:3–27CrossRef Chang C-C (2011) LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol 2:3–27CrossRef
17.
Zurück zum Zitat Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL (2014) Evaluation of mild cognitive impairment subtypes in Parkinson’s disease. Mov Disord 29:756–764CrossRefPubMedPubMedCentral Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL (2014) Evaluation of mild cognitive impairment subtypes in Parkinson’s disease. Mov Disord 29:756–764CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20:273–297 Cortes C, Vapnik V (1995) Support-vector networks. Mach Learn 20:273–297
19.
Zurück zum Zitat Cortese A, Amano K, Koizumi A, Lau H, Kawato M (2017) Decoded fMRI neurofeedback can induce bidirectional confidence changes within single participants. Neuroimage 149:323–337CrossRefPubMedPubMedCentral Cortese A, Amano K, Koizumi A, Lau H, Kawato M (2017) Decoded fMRI neurofeedback can induce bidirectional confidence changes within single participants. Neuroimage 149:323–337CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jimenez-Urbieta H, Rodriguez-Oroz MC (2016) Biomarkers for dementia and mild cognitive impairment in Parkinson’s disease. Mov Disord 31:861–881CrossRefPubMed Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jimenez-Urbieta H, Rodriguez-Oroz MC (2016) Biomarkers for dementia and mild cognitive impairment in Parkinson’s disease. Mov Disord 31:861–881CrossRefPubMed
21.
Zurück zum Zitat Dos Santos Kawata KH, Hashimoto R, Nishio Y, Hayashi A, Ogawa N, Kanno S, Hiraoka K, Yokoi K, Iizuka O, Mori E (2012) A validation study of the Japanese version of the Addenbrooke’s cognitive examination-revised. Dement Geriatr Cogn Dis Extra 2:29–37CrossRefPubMedPubMedCentral Dos Santos Kawata KH, Hashimoto R, Nishio Y, Hayashi A, Ogawa N, Kanno S, Hiraoka K, Yokoi K, Iizuka O, Mori E (2012) A validation study of the Japanese version of the Addenbrooke’s cognitive examination-revised. Dement Geriatr Cogn Dis Extra 2:29–37CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRefPubMed Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324CrossRefPubMed
23.
Zurück zum Zitat Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust WJ (1994) Cortical glucose metabolism in Parkinson’s disease without dementia. Neurobiol Aging 15:329–335CrossRefPubMed Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust WJ (1994) Cortical glucose metabolism in Parkinson’s disease without dementia. Neurobiol Aging 15:329–335CrossRefPubMed
24.
Zurück zum Zitat Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K (2005) A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25:1325–1335CrossRefPubMed Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K (2005) A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25:1325–1335CrossRefPubMed
25.
26.
Zurück zum Zitat Esposito F, Tessitore A, Giordano A, De Micco R, Paccone A, Conforti R, Pignataro G, Annunziato L, Tedeschi G (2013) Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson’s disease by levodopa. Brain 136:710–725CrossRefPubMed Esposito F, Tessitore A, Giordano A, De Micco R, Paccone A, Conforti R, Pignataro G, Annunziato L, Tedeschi G (2013) Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson’s disease by levodopa. Brain 136:710–725CrossRefPubMed
27.
Zurück zum Zitat Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356CrossRefPubMed Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356CrossRefPubMed
28.
Zurück zum Zitat Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA 106:7209–7214CrossRefPubMedPubMedCentral Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA 106:7209–7214CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Fox MD, Greicius M (2010) Clinical applications of resting state functional connectivity. Front Syst Neurosci 4:19PubMedPubMedCentral Fox MD, Greicius M (2010) Clinical applications of resting state functional connectivity. Front Syst Neurosci 4:19PubMedPubMedCentral
30.
Zurück zum Zitat Gottlich M, Munte TF, Heldmann M, Kasten M, Hagenah J, Kramer UM (2013) Altered resting state brain networks in Parkinson’s disease. PLoS ONE 8:e77336CrossRefPubMedPubMedCentral Gottlich M, Munte TF, Heldmann M, Kasten M, Hagenah J, Kramer UM (2013) Altered resting state brain networks in Parkinson’s disease. PLoS ONE 8:e77336CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Harrington DL, Shen Q, Castillo GN, Filoteo JV, Litvan I, Takahashi C, French C (2017) Aberrant intrinsic activity and connectivity in cognitively normal Parkinson’s disease. Front Aging Neurosci 9:197CrossRefPubMedPubMedCentral Harrington DL, Shen Q, Castillo GN, Filoteo JV, Litvan I, Takahashi C, French C (2017) Aberrant intrinsic activity and connectivity in cognitively normal Parkinson’s disease. Front Aging Neurosci 9:197CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Hendershott TR, Zhu D, Llanes S, Poston KL (2017) Domain-specific accuracy of the montreal cognitive assessment subsections in Parkinson’s disease. Parkinsonism Relat Disord 38:31–34CrossRefPubMed Hendershott TR, Zhu D, Llanes S, Poston KL (2017) Domain-specific accuracy of the montreal cognitive assessment subsections in Parkinson’s disease. Parkinsonism Relat Disord 38:31–34CrossRefPubMed
33.
Zurück zum Zitat Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42:1142–1146CrossRefPubMed Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42:1142–1146CrossRefPubMed
34.
Zurück zum Zitat Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55–65CrossRefPubMedPubMedCentral Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ (2017) Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol 16:55–65CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) Fsl. Neuroimage 62:782–790CrossRefPubMed Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) Fsl. Neuroimage 62:782–790CrossRefPubMed
36.
Zurück zum Zitat Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM (2009) Dementia and visual hallucinations associated with limbic pathology in Parkinson’s disease. Parkinsonism Relat Disord 15:196–204CrossRefPubMed Kalaitzakis ME, Christian LM, Moran LB, Graeber MB, Pearce RK, Gentleman SM (2009) Dementia and visual hallucinations associated with limbic pathology in Parkinson’s disease. Parkinsonism Relat Disord 15:196–204CrossRefPubMed
37.
Zurück zum Zitat Kansal K, Yang Z, Fishman AM, Sair HI, Ying SH, Jedynak BM, Prince JL, Onyike CU (2017) Structural cerebellar correlates of cognitive and motor dysfunctions in cerebellar degeneration. Brain 140:707–720PubMed Kansal K, Yang Z, Fishman AM, Sair HI, Ying SH, Jedynak BM, Prince JL, Onyike CU (2017) Structural cerebellar correlates of cognitive and motor dysfunctions in cerebellar degeneration. Brain 140:707–720PubMed
38.
Zurück zum Zitat Kashihara K, Kondo T, Mizuno Y, Kikuchi S, Kuno S, Hasegawa K, Hattori N, Mochizuki H, Mori H, Murata M, Nomoto M, Takahashi R, Takeda A, Tsuboi Y, Ugawa Y, Yamanmoto M, Yokochi F, Yoshii F, Stebbins GT, Tilley BC, Luo S, Wang L, LaPelle NR, Goetz CG, Group M-UJVS (2014) Official Japanese Version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale: validation against the original English version. Mov Disord Clin Pract 1:200–212CrossRefPubMedPubMedCentral Kashihara K, Kondo T, Mizuno Y, Kikuchi S, Kuno S, Hasegawa K, Hattori N, Mochizuki H, Mori H, Murata M, Nomoto M, Takahashi R, Takeda A, Tsuboi Y, Ugawa Y, Yamanmoto M, Yokochi F, Yoshii F, Stebbins GT, Tilley BC, Luo S, Wang L, LaPelle NR, Goetz CG, Group M-UJVS (2014) Official Japanese Version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale: validation against the original English version. Mov Disord Clin Pract 1:200–212CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213CrossRefPubMed Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213CrossRefPubMed
40.
Zurück zum Zitat Krajcovicova L, Mikl M, Marecek R, Rektorova I (2012) The default mode network integrity in patients with Parkinson’s disease is levodopa equivalent dose-dependent. J Neural Transm (Vienna) 119:443–454CrossRef Krajcovicova L, Mikl M, Marecek R, Rektorova I (2012) The default mode network integrity in patients with Parkinson’s disease is levodopa equivalent dose-dependent. J Neural Transm (Vienna) 119:443–454CrossRef
41.
Zurück zum Zitat Laird AR, Fox PM, Eickhoff SB, Turner JA, Ray KL, McKay DR, Glahn DC, Beckmann CF, Smith SM, Fox PT (2011) Behavioral interpretations of intrinsic connectivity networks. J Cogn Neurosci 23:4022–4037CrossRefPubMedPubMedCentral Laird AR, Fox PM, Eickhoff SB, Turner JA, Ray KL, McKay DR, Glahn DC, Beckmann CF, Smith SM, Fox PT (2011) Behavioral interpretations of intrinsic connectivity networks. J Cogn Neurosci 23:4022–4037CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Lin CH, Wu RM (2015) Biomarkers of cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord 21:431–443CrossRefPubMed Lin CH, Wu RM (2015) Biomarkers of cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord 21:431–443CrossRefPubMed
43.
Zurück zum Zitat Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349–356CrossRefPubMedPubMedCentral Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349–356CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat McColgan P, Evans JR, Breen DP, Mason SL, Barker RA, Williams-Gray CH (2012) Addenbrooke’s Cognitive Examination-Revised for mild cognitive impairment in Parkinson’s disease. Mov Disord 27:1173–1177CrossRefPubMed McColgan P, Evans JR, Breen DP, Mason SL, Barker RA, Williams-Gray CH (2012) Addenbrooke’s Cognitive Examination-Revised for mild cognitive impairment in Parkinson’s disease. Mov Disord 27:1173–1177CrossRefPubMed
45.
Zurück zum Zitat Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085CrossRefPubMed
46.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRefPubMed
47.
Zurück zum Zitat Ng B, Varoquaux G, Poline JB, Thirion B, Greicius MD, Poston KL (2017) Distinct alterations in Parkinson’s medication-state and disease-state connectivity. Neuroimage Clin 16:575–585CrossRefPubMedPubMedCentral Ng B, Varoquaux G, Poline JB, Thirion B, Greicius MD, Poston KL (2017) Distinct alterations in Parkinson’s medication-state and disease-state connectivity. Neuroimage Clin 16:575–585CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15:1–25CrossRefPubMed Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15:1–25CrossRefPubMed
49.
Zurück zum Zitat Olde Dubbelink KT, Schoonheim MM, Deijen JB, Twisk JW, Barkhof F, Berendse HW (2014) Functional connectivity and cognitive decline over 3 years in Parkinson disease. Neurology 83:2046–2053CrossRefPubMed Olde Dubbelink KT, Schoonheim MM, Deijen JB, Twisk JW, Barkhof F, Berendse HW (2014) Functional connectivity and cognitive decline over 3 years in Parkinson disease. Neurology 83:2046–2053CrossRefPubMed
50.
Zurück zum Zitat Pedersen KF, Larsen JP, Tysnes OB, Alves G (2017) Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88:767–774CrossRefPubMed Pedersen KF, Larsen JP, Tysnes OB, Alves G (2017) Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88:767–774CrossRefPubMed
51.
Zurück zum Zitat Peraza LR, Nesbitt D, Lawson RA, Duncan GW, Yarnall AJ, Khoo TK, Kaiser M, Firbank MJ, O’Brien JT, Barker RA, Brooks DJ, Burn DJ, Taylor JP (2017) Intra- and inter-network functional alterations in Parkinson’s disease with mild cognitive impairment. Hum Brain Mapp 38:1702–1715CrossRefPubMed Peraza LR, Nesbitt D, Lawson RA, Duncan GW, Yarnall AJ, Khoo TK, Kaiser M, Firbank MJ, O’Brien JT, Barker RA, Brooks DJ, Burn DJ, Taylor JP (2017) Intra- and inter-network functional alterations in Parkinson’s disease with mild cognitive impairment. Hum Brain Mapp 38:1702–1715CrossRefPubMed
52.
Zurück zum Zitat Petersen RC, Morris JC (2005) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62:1160–1163 (discussion 1167) CrossRefPubMed Petersen RC, Morris JC (2005) Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 62:1160–1163 (discussion 1167) CrossRefPubMed
53.
Zurück zum Zitat Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Muller ML, Albin RL, Frey KA (2015) Amyloid deposition in Parkinson’s disease and cognitive impairment: a systematic review. Mov Disord 30:928–935CrossRefPubMedPubMedCentral Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Muller ML, Albin RL, Frey KA (2015) Amyloid deposition in Parkinson’s disease and cognitive impairment: a systematic review. Mov Disord 30:928–935CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59:2142–2154CrossRefPubMed Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59:2142–2154CrossRefPubMed
55.
Zurück zum Zitat Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, Mast B, Tang-Wai D, Lang AE, Marras C (2013) Impact of mild cognitive impairment on health-related quality of life in Parkinson’s disease. Dement Geriatr Cogn Disord 36:67–75CrossRefPubMed Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, Mast B, Tang-Wai D, Lang AE, Marras C (2013) Impact of mild cognitive impairment on health-related quality of life in Parkinson’s disease. Dement Geriatr Cogn Disord 36:67–75CrossRefPubMed
56.
Zurück zum Zitat Rittman T, Ghosh BC, McColgan P, Breen DP, Evans J, Williams-Gray CH, Barker RA, Rowe JB (2013) The Addenbrooke’s Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry 84:544–551CrossRefPubMedPubMedCentral Rittman T, Ghosh BC, McColgan P, Breen DP, Evans J, Williams-Gray CH, Barker RA, Rowe JB (2013) The Addenbrooke’s Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders. J Neurol Neurosurg Psychiatry 84:544–551CrossRefPubMedPubMedCentral
57.
Zurück zum Zitat Robbins TW, Cools R (2014) Cognitive deficits in Parkinson’s disease: a cognitive neuroscience perspective. Mov Disord 29:597–607CrossRefPubMed Robbins TW, Cools R (2014) Cognitive deficits in Parkinson’s disease: a cognitive neuroscience perspective. Mov Disord 29:597–607CrossRefPubMed
58.
Zurück zum Zitat Scharnowski F, Veit R, Zopf R, Studer P, Bock S, Diedrichsen J, Goebel R, Mathiak K, Birbaumer N, Weiskopf N (2015) Manipulating motor performance and memory through real-time fMRI neurofeedback. Biol Psychol 108:85–97CrossRefPubMedPubMedCentral Scharnowski F, Veit R, Zopf R, Studer P, Bock S, Diedrichsen J, Goebel R, Mathiak K, Birbaumer N, Weiskopf N (2015) Manipulating motor performance and memory through real-time fMRI neurofeedback. Biol Psychol 108:85–97CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Shirer WR, Ryali S, Rykhlevskaia E, Menon V, Greicius MD (2012) Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb Cortex 22:158–165CrossRefPubMed Shirer WR, Ryali S, Rykhlevskaia E, Menon V, Greicius MD (2012) Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb Cortex 22:158–165CrossRefPubMed
60.
Zurück zum Zitat Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, Filippini N, Watkins KE, Toro R, Laird AR, Beckmann CF (2009) Correspondence of the brain’s functional architecture during activation and rest. Proc Natl Acad Sci USA 106:13040–13045CrossRefPubMedPubMedCentral Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, Filippini N, Watkins KE, Toro R, Laird AR, Beckmann CF (2009) Correspondence of the brain’s functional architecture during activation and rest. Proc Natl Acad Sci USA 106:13040–13045CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Stoodley CJ, Valera EM, Schmahmann JD (2012) Functional topography of the cerebellum for motor and cognitive tasks: an fMRI study. Neuroimage 59:1560–1570CrossRefPubMed Stoodley CJ, Valera EM, Schmahmann JD (2012) Functional topography of the cerebellum for motor and cognitive tasks: an fMRI study. Neuroimage 59:1560–1570CrossRefPubMed
62.
Zurück zum Zitat Szewczyk-Krolikowski K, Menke RA, Rolinski M, Duff E, Salimi-Khorshidi G, Filippini N, Zamboni G, Hu MT, Mackay CE (2014) Functional connectivity in the basal ganglia network differentiates PD patients from controls. Neurology 83:208–214CrossRefPubMedPubMedCentral Szewczyk-Krolikowski K, Menke RA, Rolinski M, Duff E, Salimi-Khorshidi G, Filippini N, Zamboni G, Hu MT, Mackay CE (2014) Functional connectivity in the basal ganglia network differentiates PD patients from controls. Neurology 83:208–214CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat Tahmasian M, Bettray LM, van Eimeren T, Drzezga A, Timmermann L, Eickhoff CR, Eickhoff SB, Eggers C (2015) A systematic review on the applications of resting-state fMRI in Parkinson’s disease: does dopamine replacement therapy play a role? Cortex 73:80–105CrossRefPubMed Tahmasian M, Bettray LM, van Eimeren T, Drzezga A, Timmermann L, Eickhoff CR, Eickhoff SB, Eggers C (2015) A systematic review on the applications of resting-state fMRI in Parkinson’s disease: does dopamine replacement therapy play a role? Cortex 73:80–105CrossRefPubMed
64.
Zurück zum Zitat Tessitore A, Esposito F, Vitale C, Santangelo G, Amboni M, Russo A, Corbo D, Cirillo G, Barone P, Tedeschi G (2012) Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology 79:2226–2232CrossRefPubMed Tessitore A, Esposito F, Vitale C, Santangelo G, Amboni M, Russo A, Corbo D, Cirillo G, Barone P, Tedeschi G (2012) Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology 79:2226–2232CrossRefPubMed
66.
Zurück zum Zitat Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, Bak TH, Shang H (2015) Screening for cognitive impairment in a Chinese ALS population. Amyotroph Lateral Scler Frontotemporal Degener 16:40–45CrossRefPubMed Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, Bak TH, Shang H (2015) Screening for cognitive impairment in a Chinese ALS population. Amyotroph Lateral Scler Frontotemporal Degener 16:40–45CrossRefPubMed
67.
68.
Zurück zum Zitat Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256:240–246CrossRefPubMed Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256:240–246CrossRefPubMed
69.
70.
Zurück zum Zitat Yahata N, Morimoto J, Hashimoto R, Lisi G, Shibata K, Kawakubo Y, Kuwabara H, Kuroda M, Yamada T, Megumi F, Imamizu H, Nanez JE Sr, Takahashi H, Okamoto Y, Kasai K, Kato N, Sasaki Y, Watanabe T, Kawato M (2016) A small number of abnormal brain connections predicts adult autism spectrum disorder. Nat Commun 7:11254CrossRefPubMedPubMedCentral Yahata N, Morimoto J, Hashimoto R, Lisi G, Shibata K, Kawakubo Y, Kuwabara H, Kuroda M, Yamada T, Megumi F, Imamizu H, Nanez JE Sr, Takahashi H, Okamoto Y, Kasai K, Kato N, Sasaki Y, Watanabe T, Kawato M (2016) A small number of abnormal brain connections predicts adult autism spectrum disorder. Nat Commun 7:11254CrossRefPubMedPubMedCentral
Metadaten
Titel
Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson’s disease
verfasst von
Kazuya Kawabata
Hirohisa Watanabe
Kazuhiro Hara
Epifanio Bagarinao
Noritaka Yoneyama
Aya Ogura
Kazunori Imai
Michihito Masuda
Takamasa Yokoi
Reiko Ohdake
Yasuhiro Tanaka
Takashi Tsuboi
Tomohiko Nakamura
Masaaki Hirayama
Mizuki Ito
Naoki Atsuta
Satoshi Maesawa
Shinji Naganawa
Masahisa Katsuno
Gen Sobue
Publikationsdatum
01.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 3/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8755-5

Weitere Artikel der Ausgabe 3/2018

Journal of Neurology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.